Comparison of the Effects of Melatonin and Oxazepam on Anxiety Levels and Sleep Quality in Patients With ST-Segment-Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention: A Randomized Clinical Trial By Guilherme GuainJune 30, 2022
A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood By Guilherme GuainJune 30, 2022
Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study By Guilherme GuainJune 30, 2022
Antidepressant action of melatonin in the treatment of Delayed Sleep Phase Syndrome By Guilherme GuainJune 30, 2022
Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis By Guilherme GuainJune 30, 2022
Efficacy and safety of melatonin for sleep onset insomnia in children and adolescents: a meta-analysis of randomized controlled trials By Guilherme GuainJune 30, 2022
Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders By Guilherme GuainJune 30, 2022
Scientific Opinion on the substantiation of a health claim related to melatonin and reduction of sleep onset latency (ID 1698, 1780, 4080) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 By Guilherme GuainJune 30, 2022
Efficacy of melatonin in the treatment of endometriosis: a phase II, randomized, double-blind, placebo-controlled trial By Guilherme GuainJune 30, 2022
